Daohong Zhou
individual
About
Daohong Zhou is a physician-scientist focused on senolytic drug discovery, PROTAC-based therapeutics, and cancer translational research. Public sources identify Zhou as the Joe R. and Terry Lozano Long Distinguished Chair of Developmental Therapeutics at UT Health San Antonio, Co-Director of the Center for Innovative Drug Discovery, and Associate Director for Drug Development at Mays Cancer Center. Zhou is also a board member and scientific co-founder of Dialectic Therapeutics, where the work helped advance DT2216 into the clinic.
Areas of interest
senolyticsaging biologylongevity therapeuticscancer therapeuticsdrug discoverytranslational medicinePROTACsapoptosis-targeting therapeutics